AAV gene therapy continues to woo investors

被引：0
|
作者：
Barbara Cassasus
机构：
来源：
Nature Biotechnology | 2014年 / 32卷 / 4期
关键词：
D O I：
10.1038/nbt0414-302a
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：302 / 302
相关论文
共 50 条
  • [1] Australia's research continues to woo industry
    Harrigan, P
    LANCET, 1996, 347 (8998): : 390 - 390
  • [2] Gene therapy boom continues
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (10) : 737 - 737
  • [3] Immunology of AAV gene therapy
    Wilson, James
    HUMAN GENE THERAPY, 2007, 18 (10) : 943 - 943
  • [4] AAV Gene Therapy for Phenylketonuria
    Ashley, Scott N.
    Nordin, Jayme M. L.
    Draper, Christine
    Greig, Jenny A.
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 312 - 313
  • [5] AAV Vector Mobilization is a Concern for AAV Gene Therapy
    Song, Liujiang
    Hirsch, Matthew
    MOLECULAR THERAPY, 2020, 28 (04) : 445 - 445
  • [6] NIH recombinant DNA advisory committee continues to ponder adverse event associated with AAV gene therapy trial
    Williams, David A.
    MOLECULAR THERAPY, 2008, 16 (03) : 427 - 428
  • [7] Chem-AAV: Chemically Modified AAV for Gene Therapy
    Mevel, Mathieu
    Bouzelha, Mohammed
    Dubreil, Laurence
    Toublanc, Estelle
    Blouin, Veronique
    Gouin, Sebastien
    Moullier, Philippe
    Deniaud, David
    Ayuso, Eduard
    MOLECULAR THERAPY, 2017, 25 (05) : 258 - 258
  • [8] AAV gene therapy for Dravet Syndrome
    Diaz, Juan Antinao
    Counsell, John
    Morris, Gareth
    Buckley, Suzanne
    Davidge, Joanna
    Schorge, Stephanie
    Waddington, Simon
    Karda, Rajvinder
    HUMAN GENE THERAPY, 2018, 29 (07) : A9 - A9
  • [9] Immunogenicity and toxicity of AAV gene therapy
    Ertl, Hildegund C. J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] AAV gene therapy vectors in the TMJ
    Brouxhon, Sabine M.
    O'Banion, Michael Kerry
    Kyrkanides, Stephanos
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2022, 8 (06): : 1561 - 1566
12345